Protagonist Therapeutics Inc (PTGX)
Net profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 275,188 | -78,955 | -123,413 | -122,627 | -66,150 |
| Revenue | US$ in thousands | 434,433 | 60,000 | 26,581 | 27,357 | 28,628 |
| Net profit margin | 63.34% | -131.59% | -464.29% | -448.25% | -231.07% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $275,188K ÷ $434,433K
= 63.34%
Protagonist Therapeutics Inc's net profit margin has displayed significant fluctuations over the years based on the provided data. The margin was negative for the years ending December 31, 2020, December 31, 2021, December 31, 2022, and December 31, 2023, indicating that the company incurred losses exceeding its revenue during these periods.
The negative net profit margins suggest that the company's expenses exceeded its revenues, resulting in substantial losses. However, it is important to note that the net profit margin improved drastically by the year ending December 31, 2024, jumping to a positive 63.34%. This positive margin signifies that the company was able to generate substantial profit relative to its total revenue during that year.
The stark variation in the net profit margin over the years could be indicative of fluctuations in the company's financial performance, cost structures, or strategic shifts impacting its profitability. Further analysis of the company's financial statements and business operations would be necessary to fully understand the factors driving these changes in the net profit margin.
Peer comparison
Dec 31, 2024